Climb Bio, Inc. (CLYM): Cash & Equivalents
$35.69M
As of 2025-12-31
$44.11M
As of 2026-06-30
-6.4%
3-year compound annual growth
+11.7%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $35.69M | -59.1% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $87.23M | -6.3% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $93.11M | +113.6% | 2025-03-25, Balance as of period end |
| 2022-12-31 | $43.59M | -7.1% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $46.92M | +129.0% | 2023-03-06, Balance as of period end |
| 2020-12-31 | $20.49M | n/a | 2022-03-07, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | 2025-12-31 | $35.69M | -59.1% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 2025-12-31 | $28.49M | +65.7% |
| Eledon Pharmaceuticals, Inc. (ELDN) | 2025-12-31 | $22.81M | +11.0% |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $37.07M | +213.8% |
| Apimeds Pharmaceuticals US, Inc. (APUS) | 2025-12-31 | $1.64M | n/m |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | $37.73M | -18.1% |
| Cypherpunk Technologies Inc. (CYPH) | 2025-12-31 | $14.04M | -70.3% |
| Transcode Therapeutics, Inc. (RNAZ) | 2025-12-31 | $17.81M | +206.5% |
| PepGen Inc. (PEPG) | 2025-12-31 | $60.51M | +22.4% |
Compare CLYM, CRBP, ELDN, GYRE side by side · Screen every company in Pharmaceutical Preparations ↗